Cargando…
Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
BACKGROUND: Metastatic breast cancer (BCa) is most often diagnosed months after completion of treatment of the primary tumor when a patient reports physical symptoms. Besides a physical examination, no other alternative recurrence screening method is recommended for routine follow-up care. Detection...
Autores principales: | Evans, Rick L., Pottala, James V., Nagata, Satoshi, Egland, Kristi A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793406/ https://www.ncbi.nlm.nih.gov/pubmed/29386014 http://dx.doi.org/10.1186/s12885-018-4022-5 |
Ejemplares similares
-
SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer
por: Hultgren, Elizabeth M., et al.
Publicado: (2017) -
Panel of autoantibodies against multiple tumor‐associated antigens for detecting gastric cancer
por: Hoshino, Isamu, et al.
Publicado: (2017) -
Autoantibodies to Tumor-Associated Antigens in Breast Carcinoma
por: Piura, Ettie, et al.
Publicado: (2010) -
SUSD2 expression correlates with decreased metastasis and increased survival in a high-grade serous ovarian cancer xenograft murine model
por: Sheets, Jordan N., et al.
Publicado: (2020) -
SUSD2 Proteolytic Cleavage Requires the GDPH Sequence and Inter-Fragment Disulfide Bonds for Surface Presentation of Galectin-1 on Breast Cancer Cells
por: Patrick, Mitch E., et al.
Publicado: (2019)